October 19, 2017 | A cancer treatment drug developed by Israeli-based biotech company Kite Pharma has been approved by The U.S. Food and Drug Administration. The company’s Yescarta drug is approved for treatment of certain kinds of blood cancer called non-Hodgkin lymphoma. It uses a technology to take out T-cells (white blood cells that fight infection), […]

Kite Pharma specializes in developing therapies that use the patient’s immune system to treat cancer.